Citation Impact
Citing Papers
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
2012
Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease
2007 Standout
Pretransplant Immediately Early-1-Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation
2013
A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION
1999
A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplant
2014
Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
2010
The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay
1996
Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment
2011
Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis
2012
Delayed graft function in kidney transplantation
2004 Standout
Nitric oxide synthases: regulation and function
2011 Standout
The role of inflammasomes in kidney disease
2019
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells.
1995
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy
2016
Effect of mycophenolic acid on TNFα‐induced expression of cell adhesion molecules in human venous endothelial cells in vitro
1997
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
2012
Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
2014
TGF-β: the master regulator of fibrosis
2016 Standout
Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago
2015
Apigenin Inhibits Tumor Necrosis Factor‐Induced Intercellular Adhesion Molecule‐1 Upregulation In Vivo
1996
Guillain-Barré syndrome
2016 Standout
Hereditary Hemorrhagic Telangiectasia
1995 Standout
Hemofiltration of Recombinant Hirudin by Different Hemodialyzer Membranes
2007
Uric Acid and Cardiovascular Risk
2008 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome––an update of treatment modalities and pathophysiological cognition
2003
Flavonoids: antioxidants or signalling molecules?
2004 Standout
HEPARIN‐INDUCED THROMBOCYTOPENIA IN DIALYSIS: Alternative Methods of Anticoagulation for Dialysis‐dependent Patients with Heparin‐induced Thrombocytopenia
2003
Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment
2014
Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2014
Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation
2003
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
2017
Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain–Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood
2001
EAU Guidelines for the Management of Urinary and Male Genital Tract Infections<sup>1</sup>
2001
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
A tense situation: forcing tumour progression
2009 Standout
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
CMV: Prevention, Diagnosis and Therapy
2013
A neglected epidemic: fungal infections in HIV/AIDS
2014
Transplant trials with Tregs: perils and promises
2017
Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation
2014
Mycophenolate mofetil and its mechanisms of action
2000 Standout
High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy
2011
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
2009
Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2012
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
2012
Cytomegalovirus in Solid Organ Transplantation
2013
Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients
2013
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Infection in Solid-Organ Transplant Recipients
2007 Standout
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients
2010
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Effects of Estrogen, Progesterone, and Combination Exposure on Interleukin-1β-Induced Expression of VCAM-1, ICAM-1, PECAM, and E-Selectin by Human Female Iliac Artery Endothelial Cells
2002
Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial Cells
1998
Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes
1994
Immunotherapy in Elderly Transplant Recipients
2009
Tubulointerstitial damage and progression of renal failure
2005
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
2016
Long‐Term Citrate Anticoagulation for High‐Flux Haemodialysis in a Patient with Heparin‐Induced Thrombocytopenia Type II
2002
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients
2015
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2017
The Wound Healing Process: An Overview of the Cellular and Molecular Mechanisms
2009 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
2013
The Mechanisms of Action of PPARs
2002 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis
2015
A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.
1995
New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients
2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
2014
Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
2010
The effect of sirolimus‐based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation
2015
Antiviral Drug Resistance of Human Cytomegalovirus
2010
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
1996 Standout
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective
2015
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Potential role of CC chemokine receptor 6 in prediction of late‐onset cytomegalovirus infection following solid organ transplant
2015
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Colonization by Pneumocystis jirovecii and Its Role in Disease
2012
Hidden Killers: Human Fungal Infections
2012 Standout
Valganciclovir Prophylaxis against Cytomegalovirus Impairs Lymphocyte Proliferation and Activation in Renal Transplant Recipients
2011
Clinical Utility of Molecular Surveillance for Cytomegalovirus After Antiviral Prophylaxis in High-Risk Solid Organ Transplant Recipients
2011
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of I.A. Hauser being referenced
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
2010
Mechanisms of Everolimus‐Induced Glomerulosclerosis After Glomerular Injury in the Rat
2005
A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients
2008
A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection
2012
Clinical aspects of renal transplantation in polycystic kidney disease
2002
IL-18 is expressed in the intercalated cell of human kidney
2007
Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients
2010
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
1999
Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro.
1993
Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion.
1993
CMV VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY AFTER RENAL TRANSPLANTATION: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
2010
Abstracts 1–142
2000
THE IMPACT STUDY: 100-DAY VS 200-DAY PROPHYLAXIS WITH VALGANCICLOVIR (VALCYTE®) TO REDUCE CMV DISEASE POST-TRANSPLANT IS COST-EFFECTIVE WITHIN US HEALTH CARE SETTING
2010
Treatment of Hirudin Overdosage in a Patient with Chronic Renal Failure
1999